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Abstract 
Rationale: Endophthalmitis, which is one of the severest complications of cataract surgeries, can 
seriously threaten vision and even lead to irreversible blindness owing to its complicated 
microenvironment, including both local bacterial infection and severe inflammation. It is urgent to 
develop a comprehensive treatment for both anti-bacterial and anti-inflammatory effects. 
Methods: Herein, we developed AuAgCu2O-bromfenac sodium nanoparticles (AuAgCu2O-BS NPs), 
which was designed to combine anti-bacterial and anti-inflammatory effects for integrated therapy of 
endophthalmitis after cataract surgery. The AuAgCu2O-BS NPs could eradicate methicillin-resistant 
Staphylococcus aureus (MRSA) bacterial strain relied on their photodynamic effects and the release of 
metal ions (Ag+ and Cu+) by the hollow AuAgCu2O nanostructures mediated mild photothermal effects. 
The anti-inflammatory drug, bromfenac sodium, released from the nanoparticles were able to significantly 
reduce the local inflammation of the endophthalmitis and promote tissue rehabilitation. In vivo bacterial 
elimination and anti-inflammation were confirmed by a postcataract endophthalmitis rabbit model. 
Results: Excellent antibacterial ability of AuAgCu2O-BS NPs was verified both in vitro and in vivo. 
Ophthalmological clinical observation and pathologic histology analysis showed prominent treatment of 
inflammatory reaction. Importantly, the mild temperature photothermal effect not only promoted the 
release of metal ions and bromfenac sodium but also avoided the thermal damage of the surrounding 
tissues, which was more suitable for the practical application of ophthalmology due to the complex 
structure of the eyeball. Moreover, superior biocompatibility was approved by the preliminary toxicity 
investigations, including low cytotoxicity, negligible damage to major organs, and stable intraocular 
pressure. 
Conclusions: Our studies of nanosystem provide a promising synergic therapeutic strategy for 
postcataract endophthalmitis treatment with favorable prognosis and promise in clinical translations. 
Key words: endophthalmitis, antibacterial and anti-inflammation effect, mild photothermal therapy, 
nanoparticles, post-cataract Surgery  
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Introduction 
With the longevity of the population, morbidity 
and surgery of cataract have increased obviously [1]. 
The World Health Organization (WHO) reported that 
the number of visual impairment is about 285 million 
worldwide, and about 94 million people are caused by 
cataract [2]. Endophthalmitis, which is one of the 
severest complications of cataract surgeries, draws 
more attention to the public due to the large quantity 
and even worse in developing countries [3, 4]. The 
reported rate of post-operative endophthalmitis 
varies between a range of 0.04%-0.2% [1]. As an 
infectious disease, endophthalmitis is usually caused 
after pathogens including bacteria and fungus spread 
into eyes through operation and trauma while mostly 
caused by bacteria mainly including coagulase- 
negative staphylococci, Staphylococcus aureus and 
Streptococcus [5-8]. Severe infection can easily lead to 
inflammation aggravation, hypopyon, ocular 
penetrating, and even blindness [9, 10]. In the clinic, 
the common treatment is an intraocular injection of 
antibiotics, however, always along with vitrectomy 
[11] and even evisceration [12]. With the overuse and 
misuse of antibiotics and the prevalence of 
multidrug-resistant bacteria, the treatment effect of 
single antibiotic therapy is impeded [13, 14]. 
Therefore, it is urgent to develop a timely and 
effective method to treat intraocular infection. 
Recently, several antibacterial nanomaterials 
were reported due to their superiority of antibacterial 
ability with drug-resistant and drug-loading capacity 
with sustained release [15-17]. The release of 
antimicrobial agents such as metallic ions is a valid 
method [18, 19]. Because of the multiple antibacterial 
mechanisms aiming at the structure and physiological 
processes of bacteria, the NPs based antibacterial 
agents exhibit sustained broad-spectrum antibacterial 
effects [20]. For example, Ag ion and Ag-based 
compounds that can influence the cell membrane and 
exhibit broad-spectrum antimicrobial effect [21-24]. 
Besides, Cu ion can serve as an antimicrobial agent 
while its wound-healing promotion effect is approved 
[25, 26].  
As a transparent optical organ of eyeball, 
phototherapy has broad prospects on the ophthalmic 
disease. Phototherapy, including photothermal 
therapy (PTT) and photodynamic therapy (PDT), are 
widely used to treat infections and exhibit a distinct 
advantage over conventional chemical antimicrobial 
agents [27]. Considering the complex structure of the 
eye, a bactericidal strategy of mild temperature 
photothermal assisted therapy, which remains the 
antibacterial effect but reduces thermal damage to 
nearby tissues, is more suitable for endophthalmitis 
[28, 29]. PDT, which can produce reactive oxygen 
species (ROS), also shows antibacterial ability while it 
can improve the treatment effects and decrease side 
effects of PTT [30]. Consequently, the combination of 
multiple antibacterial strategies may exhibit better 
efficiency and potential application prospect.  
After cataract surgery, both severe bacterial 
infection and massive inflammation caused 
complicated local microenvironment, and are difficult 
to be cured by the antibiotic treatment. Therefore, 
effective treatment is imperative to treat and control 
the endophthalmitis disease [1]. Without appropriate 
diagnosis and treatment, postcataract ocular 
inflammation can break down the blood-ocular 
barrier and bring about serious complications like 
corneal edema, intraocular pressure spikes, cystoid 
macular edema, posterior capsule opacification and 
even irreversible vision loss [31, 32]. To reduce the 
damage caused by inflammation, topical 
corticosteroids and nonsteroidal anti-inflammatory 
drug are administered by ophthalmologists [33, 34]. 
Bromfenac sodium, as a commonly clinical used 
nonsteroidal anti-inflammatory drugs with no 
obvious side effects and exerts superior ability of the 
treatment for ophthalmic inflammatory disorders and 
has been used in the clinic for more than 10 years 
worldwide [35]. However, most of the present 
therapeutic methods mainly focus on the bactericidal 
effect, so it is urgent to develop a comprehensive 
treatment for both anti-bacterial and 
anti-inflammatory effects. Compared with previously 
reported Ag-based antibacterial core-shell NPs, 
bromfenac sodium were loaded into novel hollow 
core-shell nanoparticles could be given the 
anti-inflammatory ability of NPs [36, 37]. 
In this study, aimed at endophthalmitis after 
cataract surgery, we developed a novel 
AuAgCu2O-bromfenac sodium nanoparticles 
(AuAgCu2O-BS NPs) which were designed to 
combine anti-bacterial and anti-inflammatory effects 
to improve the therapeutic effect of endophthalmitis. 
As shown in Scheme 1, based on the hollow AuAg 
core nanoparticles structure, the nanoparticles were 
coated with Cu2O outer shell layer, and then 
bromfenac sodium was loaded to develop 
AuAgCu2O-bromfenac sodium core-shell 
nanosystem. After phacoemulsification, artificial 
intraocular lens implantation, and the establishment 
of endophthalmitis, AuAgCu2O-BS NPs were injected 
into the anterior chamber of rabbits. Assisted with 
mild photothermal effects, the release of metal ions 
(Ag+ and Cu+) could eliminate MRSA and bromfenac 
sodium could diminish inflammation reaction to 
achieve anti-bacterial and anti-inflammatory effects 
simultaneously. Bacterial colony counting, OD600 
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absorption analysis, Live/Dead double staining, ROS 
staining, transmission electron microscopy, and 
scanning electron microscopy measurement were 
used to verify the in vitro antibacterial efficacy and 
possible mechanism of the nanoparticles. Besides, the 
cell migration test confirmed the promoting healing 
effect with the mild PTT treatment strategy. As for in 
vivo therapeutic capability, bacterial colony counting, 
Gram staining, hematoxylin and eosin (H&E) 
staining, and immunohistochemical staining were 
applied to demonstrate ideal treatment outcome in a 
multi-drug resistance (MDR) bacteria-infected 
postcataract endophthalmitis rabbit model. 
Materials and Methods 
The materials and methods used are 
summarized here. For more details, refer to the 
Supplementary Methods provided in the SI file.  
Synthesis of AuAgCu2O-Bromfenac Sodium 
Hybrid Core-Shell Nanoparticles 
The hollow AuAg nanoparticles were 
synthesized in advance with the classic method of the 
Ag nanoparticles templated galvanic replacement 
reaction and then added into the 10 mL mixed 
solution of a PVP (Mw 40000, 15 mg/mL) and 
Cu(NO3)2 (0.1 M, 1 mL) aqueous solution. The 
solution was stirred for 30 min, and 10 μL of the 
N2H4·solution (35 wt%) was added. Then, the 
yellow-green hollow AuAgCu2O nanoparticles were 
centrifuged and washed. To load the bromfenac 
sodium, the AuAgCu2O dispersion solution was 
centrifuged to remove the supernatant, and a 
bromfenac sodium solution (1 mg/mL) was added 
avoiding light. After stirring for 24 h, the mixed 
solution was centrifuged, and the free bromfenac 
sodium in the supernatant was removed. The 
AuAgCu2O-BS NPs were washed thrice and 
re-dispersed in water for further use. 
 
 
Scheme 1. The schematic illustration of AuAgCu2O-BS NPs for the treatment of endophthalmitis after cataract surgery. On the basis of the hollow AuAg 
core nanoparticles structure, the nanoparticles were coated with Cu2O outer shell layer, and then bromfenac sodium was loaded to develop AuAgCu2O-bromfenac sodium 
core-shell nanosystem. After phacoemulsification, artificial intraocular lens implantation, and the establishment of endophthalmitis, the nanoparticles were injected into the 
anterior chamber. Upon the near-infrared laser irradiation, AuAgCu2O-BS NPs exhibited anti-bacterial and anti-inflammatory effects simultaneously. 
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Bromfenac Sodium, Au Ion, Ag Ion, and Cu Ion 
Release Assay 
The standard curve of the UV absorbance of 
different concentrations at 378 nm was drawn by the 
gradient concentration of bromfenac sodium solution. 
The AuAgCu2O-BS NPs solution was put into a 
dialysis bag (MWCO = 14 kDa) and dialyzed in DI 
water. The release of bromfenac sodium from these 
NPs (1 mg/mL) with/without laser (808 nm, 0.75 
W/cm2) was measured at certain time points (0-72 h 
per 12 h) from the release medium. The calibration 
curve of the released bromfenac sodium concentration 
was drawn according to the Lambert-Beer law and 
standard curve. 
Similarly, the AuAgCu2O-BS NPs solution was 
put into a dialysis bag (MWCO = 14 kDa) and 
dialyzed in DI water. These NPs (1 mg/mL) were 
irradiated with/without laser (808 nm, 0.75 W/cm2) 
and the corresponding release medium were collected 
at certain time points (0-72 h per 12 h). Then the 
release medium was measured by ICP-MS 
(PerkinElmer NexION 300X, USA) to evaluate the 
amount of the Cu ion, Ag ion and Au ion release from 
AuAgCu2O-BS NPs and diffused into medium at 
different time. 
Establishment of Endophthalmitis after 
Cataract Surgery Model 
All the experiments on animals were accredited 
by the Institutional Ethics Committee and followed 
the requirements for the care and use of laboratory 
animals of Zhejiang University. The female New 
Zealand White rabbits used in this study were 
obtained from the Zhejiang Academy of Medical 
Science (Hangzhou, China), which were 2000 g and 
between eight and nine weeks. The bacterial strain of 
MRSA was used for the rabbit endophthalmitis 
model. The rabbits were anesthetized with an 
auricular vein injection of sodium pentobarbital (30 
mg/kg) and treated with phacoemulsification surgery 
on the right eyes. Prior to surgery, the surface of the 
eye was instilled with a drop of Proparacaine 
Hydrochloride (s.a. Alcon-Couvreur n.v., Belgium) 
for topical anesthesia. Then, the lens was divided into 
smaller pieces and removed through anterior capsule 
continuous circular capsulorhexis and ultrasonic 
emulsification through a limbus incision. Afterward, 
the artificial intraocular lens (IOLs) (6 6 VISION 
TECH Co., Ltd., FV-60A, China) was implanted into 
the capsular bag. The corneal incision was closed with 
10-0 nylon sutures to prevent leakage. The same 
surgeon performed all the surgeries and procedures. 
24 h after surgery, 50 μL aqueous humor was 
aspirated from the anterior chamber, and 50 μL MRSA 
suspension (3.0 × 105 CFU/mL) was injected to 
establish an experimental model of endophthalmitis 
after cataract surgery.  
In Vivo Treatment Effect Analysis 
24 h after the injection of MRSA, the rabbits were 
divided into four groups (n = 3/group) as follows: 
untreated, AuAgCu2O NPs (21.6 μg/mL, 50 μL), 
AuAgCu2O NPs (21.6 μg/mL, 50 μL) irradiated with 
an 808 nm laser (0.75 W/cm2, 10 min), AuAgCu2O-BS 
NPs (21.6 μg/mL, 50 μL), and AuAgCu2O-BS NPs 
(21.6 μg/mL, 50 μL) irradiated with an 808 nm laser 
(0.75 W/cm2, 10 min). AuAgCu2O NPs or 
AuAgCu2O-BS NPs were injected into the anterior 
chamber. To compare the therapeutic efficacy, 
ophthalmic clinical observations were performed 
every three days after the injection of the bacterial 
suspension. The anterior segment images were 
recorded with a slit lamp image system (6 6 VISION 
TECH Co., Ltd., YZ5T, China). The Clinical Grading 
Scale was applied by three independent, masked 
observers according to the numeric scale based on 
criteria proposed by Peyman et al [38] (Table 1). On 
day 12, 50 μL aqueous humor was aspirated and 
spread on LB plates. The number of CFUs was 
calculated based on CFU emergence. All groups of 
rabbits were euthanized on the twelfth day, and 
infected tissue was excised for pathological analysis. 
For the histopathological analysis, tissue samples 
were fixed in 4% paraformaldehyde, dehydrated, 
embedded in paraffin, and sectioned into four μm 
slices. These tissue slides were stained with 
hematoxylin and eosin (H&E) and Gram. 
High-resolution images of all the histological slices 
were obtained and analyzed via virtual slide 
microscopy (Olympus VS120, Japan). 
 
Table 1. Clinical Grading Scale 
Score Conjunctiva Cornea Iris Vitreous Body 
0 Normal Clear Normal Clear 
1 Mild edema Focal 
edema 
Mild hyperemia Areas of vitreous haze, 
some fundus details 
visible, good red reflex 
2 Edema, mild 
hyperemia, 
slight exudate 
Diffuse 
edema 
Marked hyperemia Moderate Vitreous haze, 
fundus details not clear, 
partial red reflex 
3 Edema, mild 
hyperemia, 
heavy exudate 
Opaque Marked hyperemia, 
engorged vessels, 
synechia, irregular 
pupil 
No red reflex 
 
Measurements of IOP 
The intraocular pressure (IOP) of New Zealand 
Rabbits was noninvasively measured with Tono-Pen 
XL (Reichert TONO-PEN XL Tonometer, USA) every 
three days. It was calibrated as instructed in the 
manufacturer’s manual before the first use. Before the 
measurement, the rabbit’s right eye was treated with a 
drop of Proparacaine Hydrochloride (s.a. Alcon- 
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Couvreur n.v., Belgium). The result of the IOP was the 
average of three measurements for each eye. 
Results and Discussion 
Preparation and Characterization of 
AuAgCu2O-BS NPs 
The AuAgCu2O-BS NPs were prepared for 
endophthalmitis after cataract surgery, which enables 
the anti-bacterial and anti-inflammatory ability 
simultaneously. For this purpose, the hollow AuAg 
nanoparticles were first synthesized by the Ag 
nanoparticles templated galvanic replacement 
reaction, and then a Cu2O layer was grown on its 
surface under the support of polyvinylpyrrolidone 
molecules (PVP). The diffraction peaks in the X-ray 
powder diffraction (XRD, Figure 1A) verified that 
these synthetic nanoparticles were composed of 
AuAg (JCPDS: #65-8424) and Cu2O (JCPDS: 
#65-3288). Furthermore, AuAgCu2O NPs with a mean 
size of 102 nm and a hollow structure were observed 
by transmission electron microscopy (TEM) (Figure 
1B). The high-resolution transmission electron 
microscopy (HRTEM) image in Figure 1B showed that 
the lattice fringes presented an AuAg–AuAg spacing 
of 0.236 nm, which corresponded to the (111) planes of 
AuAg, while the lattice fringes of Cu2O on the 
interface presented a Cu-Cu spacing of 0.247 nm, 
which corresponded to the (111) planes of Cu2O. TEM 
elemental mappings (Figure 1D) confirmed again that 
designed nanosystem was composed of Au, Ag, Cu, 
and O. Combining above results, the distribution of 
the elemental showed a core-shell structure that Au 
and Ag distributed interiorly (hollow AuAg) and Cu 
and O distributed externally (Cu2O).  
Figure 2A showed that the average 
hydrodynamic size of AuAgCu2O NPs was ~164 nm, 
which was slightly larger than that observed by the 
TEM due to the low electron density of the extended 
PVP and their hydration surface. After loading 
bromfenac sodium, the average hydrodynamic size of 
AuAgCu2O-BS NPs was about 190 nm. The stability 
was verified in different physiological solutions 
(Figure S1). Brunauer-Emmett-Teller (BET) surface 
areas (Figure 2B) and pore volume (Figure S2A) were 
applied to evaluate the capacity of drug loading. The 
specific surface area was 10.8009 m²/g, and there 
were numerous pores with a size of 7 nm and some 
larger pores, which indicated the capacity of drug 
loading by physical absorption of the nanoparticles 
 
 
Figure 1. Morphology and crystal phase characterization of AuAgCu2O NPs. (A) X-ray powder diffraction (XRD) spectrum of AuAgCu2O NPs. (B) Transmission 
electron microscopy (TEM) micrographs images of AuAgCu2O NPs. (C) The HRTEM image of AuAgCu2O NPs with core-shell structure in Figure 1A. (D) Distribution of Au 
(purple), Ag (green), Cu (red), and O (blue) elements of AuAgCu2O NPs by element mapping. 
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(Figure S3). Similar methods of drug delivery have 
also been widely reported in typical mesoporous 
silicon materials and other porous nanoparticles [39, 
40]. Bromfenac sodium showed a characteristic 
UV-Vis-NIR absorption peak at 378 nm (Figure S2B), 
and the absorption was linearly changed with the 
concentration from 0.2441 μg/mL to 250 μg/mL 
(Figure S2C). In Figure 2C, AuAgCu2O-BS NPs 
showed a strong characteristic absorption peak of the 
bromfenac sodium at 378 nm, indicating successful 
loading of bromfenac sodium (the loading efficiency 
was calculated to be 3.3%, the process of optimizing 
the loading of bromfenac sodium was shown in 
Figure S4.), and another broad localized surface 
plasmon resonance (LSPR) absorption band of hollow 
AuAg-Cu2O from 720 nm to 980 nm, which can 
induce a NIR-laser-driven photothermal effect. The 
808 nm-laser was selected because it matched the 
LSPR absorption peak of AuAgCu2O nanoparticles 
and penetrated deeper than red light or other visible 
light with less nonspecific photothermal heating of 
normal cells. Then, the photothermal ability of the 
AuAgCu2O-BS NPs solution with different 
concentrations and different laser power densities 
was evaluated (Figure 2D-F, Figure S2D,E). The 
temperature elevation of the AuAgCu2O-BS NPs 
solution varied rapidly in the first 5 min and then 
remained roughly stable from 38.2 °C to 55.9 °C with 
the concentrations from 10 μg/mL to 80 μg/mL after 
0.75 W/cm² 808 nm-laser irradiation, whereas that of 
the pure water was almost unchanged. 
 
 
Figure 2. Drug delivery, release, and photothermal properties of designed hollow AuAgCu2O-BS NPs. (A) The hydrodynamic diameter of AuAgCu2O NPs and 
AuAgCu2O-BS NPs measured by dynamic light scattering (DLS). (B) BET surface areas of AuAgCu2O NPs. (C) UV−Vis−NIR absorption spectrum of AuAgCu2O-BS NPs. (D-E) 
Thermal images and corresponding temperature change of AuAgCu2O-BS NPs with different concentrations under 808 nm NIR irradiation (0.75 W/cm2). (F) The temperature 
increment of AuAgCu2O-BS NPs with different power densities under the 808 nm laser at the concentration of 20 μg/mL. (G-I) Cumulative amounts of bromfenac sodium, Ag 
ions, and Cu ions released from the AuAgCu2O-BS NPs with or without irradiation under the 808 nm laser (0.75 W/cm2, 10 min). 
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The temperature for the solution at the 
concentration of 20 μg/mL was also adjusted with an 
increase from 33.5 °C to 44.2 °C by changing the laser 
power density from 0.25 W/cm² to 0.75 W/cm2. It is 
noteworthy that the mild photothermal-induced 
temperature below 45 °C could decrease damage to 
surrounding tissues significantly, while a high 
temperature can cause severe inflammation and 
thermal damage to surrounding tissues in some 
special organs, such as the eye [30]. 
The sustained release levels of drug or metallic 
ions are important to ensure treatment effect, so the 
deliverance behavior of the bromfenac sodium, Au 
ion, Ag ion, and Cu ion was then measured under the 
mild photothermal environment. As shown in Figure 
2H-I, the release rate was much faster in the first 24 h 
than in later. Furthermore, the release amount was 
clearly improved when treated with NIR laser 
radiation, demonstrating their possible better 
laser-induced antibacterial and anti-inflammatory 
effects. As shown in Figure S5, the cumulative 
released amounts of Au ions were almost 0 ppb due to 
its high chemical stability which made it hard to be 
oxidized to ion and went into solution [41]. The 
situation of release in PBS was also tested and it was 
similar with in DI water (Figure S6). As reported, the 
bromfenac sodium had some potential side effects of 
cornea damage [42] and conjunctiva damage [43], 
while the sustained release of the drug could reduce 
the side effects [44]. 
In Vitro Antibacterial Effect of AuAgCu2O-BS 
NPs 
The antibacterial effect of AuAgCu2O-BS NPs 
against methicillin-resistant Staphylococcus aureus 
(MRSA) was shown in Figure 3A and Figure S7A. The 
bacteria suspensions’ turbidity and optical density 
value (Figure 3B, Figure S7B) of the AuAgCu2O and 
AuAgCu2O-BS NPs without the laser exhibited 
similar antibacterial ability and was increased when 
the concentration was increased. However, when the 
nanoparticles were treated with NIR laser irradiation, 
the antibacterial ability was enhanced clearly. Almost 
all the bacteria were killed when the concentration up 
to 21.6 μg/mL. Plate counting (Figure 3C, and Figure 
S7C) and survival rates (Figure 3D, and Figure S7D) 
also showed that AuAgCu2O NPs or AuAgCu2O-BS 
NPs with the laser treatment demonstrated more 
effective function in inhibiting the reproduction of 
bacteria than that without laser irradiation. In 
addition, bromfenac sodium, as a type of non-steroid 
anti-inflammatory drug, did not exhibit an influence 
on the antibacterial effect of AuAgCu2O NPs after the 
drug loading. 
 
 
Figure 3. In vitro antibacterial effect study. (A) Images and (B) optical density (OD600) of MRSA treated with different concentrations of AuAgCu2O NPs, AuAgCu2O-BS 
NPs, AuAgCu2O NPs with a laser (0.75 W/cm2, 10 min), and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 10 min). (C) Plates images and (D) CFU count of MRSA bacterial 
colonies treated with AuAgCu2O NPs, AuAgCu2O-BS NPs, AuAgCu2O NPs with a laser (0.75 W/cm2, 10 min), and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 10 min). (***p 
< 0.001.) 
Theranostics 2020, Vol. 10, Issue 19 
 
 
http://www.thno.org 
8548 
 
Figure 4. Live/Dead double staining, ROS, and morphological analysis of antibacterial ability. (A) Bright-field and fluorescent images of Live/Dead double staining 
of MRSA treated with AuAgCu2O NPs, AuAgCu2O-BS NPs, AuAgCu2O NPs with a laser (0.75 W/cm2, 10 min), and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 10 min). 
Stained by SYTO 9 and PI. (B) Bright-field and fluorescent images of ROS levels of MRSA treated with AuAgCu2O NPs, AuAgCu2O-BS NPs, AuAgCu2O NPs with a laser (0.75 
W/cm2, 10 min), and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 10 min). Stained by DCFH-DA. (C) SEM micrographs of MRSA treated with AuAgCu2O NPs, AuAgCu2O-BS 
NPs, AuAgCu2O NPs with a laser (0.75 W/cm2, 10 min), and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 10 min). (D) TEM micrographs of MRSA treated with AuAgCu2O NPs, 
AuAgCu2O-BS NPs, AuAgCu2O NPs with a laser (0.75 W/cm2, 10 min), and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 10 min). 
 
Possible Antibacterial Mechanism 
The bactericidal function was further verified by 
a Live/Dead double staining assay. As shown in 
Figure 4A and Figure S8A, there were a large number 
of live bacteria (green fluorescence) after treated with 
AuAgCu2O or AuAgCu2O-BS NPs. In the AuAgCu2O 
NPs plus laser and AuAgCu2O-BS NPs plus laser 
groups, the percentage of dead bacteria were clearly 
increased, and almost no bacteria survived. Oxidative 
stress was recognized as an effective method to kill 
bacteria [45]. The generation of the ROS level was 
detected by DCFH-DA, which could be oxidized to 
generate fluorescent products. In Figure 4B and 
Figure S8B, MRSA treated with AuAgCu2O NPs or 
AuAgCu2O-BS NPs could hardly produce the ROS 
effect. In contrast, NIR laser-irradiated AuAgCu2O 
NPs or AuAgCu2O-BS NPs generated apparent ROS 
signals, which indicated that NIR laser could 
stimulate the generation of ROS. The morphological 
characterization and integrity of bacteria were also 
analyzed through scanning electron microscopy 
(SEM) and TEM measurements. As shown in Figure 
4C and Figure S9, in the SEM images, the bacteria 
without treatment showed unbroken spherical 
structures and smooth surfaces of MRSA. AuAgCu2O 
NPs or AuAgCu2O-BS NPs could destroy the bacteria, 
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and holes and cracks on the surface could be 
observed, which could lead to the release of 
intracellular components. NIR laser-irradiated 
AuAgCu2O NPs or AuAgCu2O-BS NPs exhibited 
much better bactericidal effects in that the bacterial 
membrane was clearly broken, and the bacterial 
membrane was completely shrunken. Besides, 
Energy-dispersive X-ray spectroscopy (EDS) analysis 
showed that there were nanoparticles on the surface 
of bacteria. This kind of interaction between NPs and 
the cell membrane might affect the permeability and 
integrity of bacteria. As shown in TEM images (Figure 
4D), the cytoplasm of the bacteria became nonuniform 
when treated with AuAgCu2O NPs or AuAgCu2O-BS 
NPs, while irregular aggregated districts appeared in 
the cytoplasm with the laser. EDS analysis showed 
that there was almost no Au, Ag and Cu in the 
bacteria without treatment. By contrast, after the 
bacteria cultured with the AuAgCu2O-BS NPs, EDS 
analysis showed the presence of Au, Ag and Cu in the 
bacteria (red rectangles), confirming the intrusion of 
released metal ions (Figure S10). In general, the 
morphological analysis was consistent with the 
results mentioned and proved the excellent 
antibacterial effect of AuAgCu2O-BS NPs. In this 
study, AuAgCu2O-BS NPs-mediated phototherapy, 
including photodynamic therapy and mild 
temperature photothermal therapy, exhibited a 
superior bactericidal function. Multiple antibacterial 
mechanisms of nanomaterials were reported, such as 
damage to the bacterial membrane, DNA damage, 
RNA effluxes, oxidative stress, photothermal 
antibacterial, inhibition of energy metabolism, and so 
on [25, 46-49]. Furthermore, the released Silver ion 
[50] and Copper ion [51] could also kill bacteria and 
the antibacterial activity of AuAg NPs was tested 
(Figure S11). Besides, the release of ions was 
promoted by irradiation which could enhance the 
antibacterial effect. In general, the combined effects of 
multiple mechanisms were the reason for the 
powerful antibacterial ability.  
In Vitro Cell Cytotoxicity, Cell Migration and 
Anti-inflammatory Effect 
In vitro cell viability was verified with three 
types of ophthalmological cells, including human 
corneal epithelial cells (HCEC), human conjunctival 
epithelial cells (HConEpic), and retinal pigment 
epithelia ARPE-19 cells. The cell viability of these 
three kinds of cells was above 85% when the con-
centration of AuAgCu2O-BS NPs reached 21.6μg/mL, 
which demonstrated low cell toxicity (Figure 5A-C). 
 
 
Figure 5. Cytotoxicity and promoting healing effects study. (A-C) Cell viability of HCEC, HConEpic, and ARPE-19 incubated with different AuAgCu2O-BS NPs 
concentrations for 48 h with laser irradiation (0.75W/cm2, 10 min). (D,E) Images of HCEC and HConEpic after treatment with bromfenac sodium, AuAgCu2O NPs, 
AuAgCu2O-BS NPs, and AuAgCu2O-BS NPs with a laser (0.75W/cm2, 10min) for 24h, scale bar=400µm. (F,G) Quantification of HCEC and HConEpic cell migration. 
(***p<0.001.) 
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 Since the endophthalmitis is commonly caused 
by surgery and trauma, the healing promotion was 
also important for the post-surgery recovery. HCEC 
and HConEpic were chosen for the in vitro scratch 
assay to evaluate their healing ability after the 
nanoparticles based treatment. In Figure 5D-G and 
Figure S12, compared with the group without 
treatment, the migration capability of the cells treated 
with bromfenac sodium did not exhibit a significant 
difference for the two types of cells. When treated 
with nanoparticles (AuAgCu2O NPs or 
AuAgCu2O-BS NPs), the cells exhibited better 
migration capabilities, and migration capabilities of 
AuAgCu2O-BS NPs were further improved when 
combined with NIR laser irradiation. As we known, 
the copper ion was demonstrated with the excellent 
capability to improve wound healing [52]. As the 
important parts of the eye, the wound of tissues such 
as cornea and iris can easily influence the vision and 
refraction so the protomting healing effect is also very 
beneficial for the treatment of the endophthalmitis. As 
mentioned above, the copper ion could be sustained 
released from AuAgCu2O-BS NPs under the laser 
irradiation, and then could promote wound healing 
after the surgery. 
In vitro anti-inflammatory effect of AuAgCu2O- 
BS NPs was also tested. In Figure S13, the result 
showed LPS could induce the inflammation of cells 
and the production of inflammatory cytokines 
including IL-1β and IL-6 was enhanced. When added 
with bromfenac sodium, the production of 
inflammation was significantly decreased which 
inferred the anti-inflammatory effect of bromfenac 
sodium. Besides, AuAgCu2O NPs did not show an 
obvious anti-inflammatory effect while the inflamma-
tion was not enhanced either. AuAgCu2O-BS NPs 
showed the good anti-inflammatory effect compared 
with LPS plus PBS group while AuAgCu2O-BS NPs 
with irradiation groups performed better. 
In Vivo Treatment Effect of Endophthalmitis 
after Cataract Surgery Model 
Since the recovery of the post-cataract surgery 
endophthalmitis was affected by surgery wounds, 
bacterial infection, and consequent inflammation 
simultaneously, the anti-bacterial effect combined 
anti-inflammatory capability of the treatment should 
be considered to improve the therapeutic effects. The 
treatment activity of endophthalmitis after cataract 
surgery was further evaluated in the MRSA-infected 
rabbit model. First, the rabbits underwent 
phacoemulsification and IOL implantation, and then 
the bacteria suspension was injected into the anterior 
chamber. Before the treatment, the inflammatory 
response, including turbid, exudation, and other 
symptoms, appeared similarly in all groups, which 
indicated that endophthalmitis occurred. As shown in 
Figure 6A and Figure S14A, a slit lamp diffuse 
illumination of the anterior segment images was 
recorded during the treatment. The inflammation of 
the control group was gradually aggravated, and 
fibrin exudation accumulated in the anterior chamber. 
Neovascularization, opacification of the cornea, 
conjunctival and congestion hyperemia, and edema of 
the iris were observed. On day 12, hypopyon clearly 
appeared, and purulent secretion increased (clinical 
grading scale: 11.667 ± 0.577). The group treated with 
AuAgCu2O NPs without laser irradiation, AuAgCu2O 
NPs with laser irradiation and AuAgCu2O-BS NPs 
without laser irradiation exhibited moderate 
therapeutic effects (clinical grading scale: AuAgCu2O 
NPs, 4.333 ± 1.154; AuAgCu2O NPs with laser 
irradiation, 3.333 ± 0.578; AuAgCu2O-BS NPs 2.667 ± 
1.000), and the condition of the endophthalmitis did 
not worsen. The AuAgCu2O-BS NPs treatment group 
showed better inflammatory response with less fibrin 
exudation, less edema, and more regular pupils. 
However, the group treated with AuAgCu2O-BS NPs 
upon NIR laser-irradiation achieved the best 
therapeutic effect and almost completely recovered 
(clinical grading scale: 0.333 ± 0.577). On day 12, there 
was no symptom of inflammation or infection, and 
the IOL could be observed clearly, which meant the 
eye reverted to transparency. The ophthalmological 
clinical grading scale also indicated that the 
inflammation was reduced effectively after the 
AuAgCu2O-BS NPs upon NIR laser-irradiation 
treatment (Figure 6B, Figure S14B). In Figure 6C, 
images of slit lamp retroillumination, which indicated 
an intraocular situation and transparency by the 
reflection on the retina, were also recorded to evaluate 
the therapeutic effect. Compared with other groups, 
the group treated with AuAgCu2O-BS NPs plus NIR 
laser-irradiation reached an optimal effect, including 
less exudation and sooner transparency. As a kind of 
bacteria infection, antibacterial treatment was most 
important for endophthalmitis. In the early stage of 
treatment, the photothermal effect of irradiation 
which could lead to the topical recruitment of 
inflammatory cells might enhance the antibacterial 
effect [53]. However, the inflammatory response 
caused by bacteria in the eye could continue for five to 
seven days after the bacteria have been killed by 
antibiotics which would seriously influence prognosis 
[54]. In the later stage, on the base of the excellent 
antibacterial effect, inflammation reaction was 
gradually diminished with the decline of 
photothermal effect and sustained release of 
anti-inflammatory drug. Therefore, the combined 
anti-bacterial anti-inflammatory capability of the 
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AuAgCu2O-BS NPs could effectively eradicate the 
bacteria, control inflammation and prevent tissue 
damage to synthetically treat the endophthalmitis. In 
addition, the IOP was measured every three days, and 
the IOP of the group without treatment gradually 
increased (Figure 6D, Figure S14C); however, it 
remained stable when treated by AuAgCu2O NPs, 
AuAgCu2O NPs with laser irradiation or 
AuAgCu2O-BS NPs and slightly decreased with 
AuAgCu2O-BS NPs upon NIR laser-irradiation 
during the 12-day treatment, which indicated that the 
treatment of nanoparticles would not lead to the 
obstruction of the aqueous inflow.  
Etiological and Inflammatory Pathologic 
Analysis 
On day 12, the aqueous humor was aspirated for 
the bacteria culture on LB plates. The group treated 
with AuAgCu2O-BS NPs with laser treatment 
exhibited excellent bactericidal ability. The combined 
treatment demonstrated significant antibacterial 
effects (p < 0.001 vs all other 3 groups), which was 
consistent with the result in vitro (Figure 7A-B, Figure 
S14D-E). AuAgCu2O without NIR irradiation could 
also release Ag ion and Cu ion and the released ion 
exhibited antibacterial activity which showed 
significant difference compared with the control 
group [20]. The therapeutic effects were further 
verified with immunohistological analysis of the 
cornea and iris tissue slices. In Figure 7C,D and Figure 
S14F, a large number of Gram-positive cocci were 
found by Gram staining of the cornea and iris tissue 
for the control group. The cocci could be reduced by 
AuAgCu2O NPs, AuAgCu2O NPs with laser 
irradiation or AuAgCu2O-BS NPs treatments. 
However, almost no bacteria could be observed in the 
group treated with AuAgCu2O-BS NPs upon NIR 
laser irradiation. 
 
 
Figure 6. In vivo therapeutic effect analysis. The infected eyes were treated with AuAgCu2O NPs, AuAgCu2O-BS NPs, and AuAgCu2O-BS NPs with a laser (0.75 W/cm2, 
10 min) in New Zealand rabbits of an MRSA-infected endophthalmitis model after cataract surgery, respectively (0, 3, 6, 9, and 12 days). (A) Photographs of slit lamp diffuse 
illumination. (B) The ophthalmological clinical grading scale of endophthalmitis. (C) Photographs of slit lamp retroillumination. (D) Measurement of intraocular pressure after 
treatment. (***p < 0.001.) 
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Figure 7. Etiological analysis of targeting effect at day 12 after treatment. (A) Photographic images of bacterial colonies and (B) counting numbers in aqueous humor 
after treatment. Gram staining analysis of MRSA in the cornea (C) and iris (D) indicated the number of Gram-positive cocci decreased. The parts framed with the black dotted 
line were enlarged, respectively. (***p < 0.001.) 
 
 For the H&E staining result (Figure 8A, Figure 
S14G and Figure S15A-B), severe infiltration of several 
inflammatory cells and an irregular structure were 
observed in the control group. Almost no 
inflammatory cells were found in the group with 
AuAgCu2O-BS NPs upon NIR laser-irradiation, and 
no structural abnormalities were observed, indicating 
no severe inflammation and damage under the mild 
photo-induced temperature during the treatment. On 
the other hand, immunohistochemical staining of 
cytokine, including IL-1β and IL-6, whose expression 
increased during inflammation [55], also validated the 
therapeutic effect (Figure 8B-C, Figure S7G and Figure 
S15C-D). The expression of proinflammatory 
cytokines IL-1β and IL-6 was significantly 
upregulated in endophthalmitis and was relevant to 
the severity [56]. Compared with the control group, 
the expression of inflammatory factors including 
IL-1β and IL-6 decreased in the group treated with 
AuAgCu2O NPs, while the expression was lower 
when treated with AuAgCu2O NPs with laser 
irradiation and AuAgCu2O-BS NPs. For the group 
treated with AuAgCu2O-BS NPs upon NIR laser 
irradiation, the expression of the IL-1β and IL-6 was 
lowest, which indicated the best therapeutic effect and 
the least inflammatory reaction. In general, the 
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anti-bacterial and anti-inflammatory ability of 
AuAgCu2O-BS NPs was improved when treated with 
NIR laser irradiation. In addition, the application 
prospect of phototherapy demonstrates some 
advantages for the treatment of ophthalmic diseases. 
Therefore, AuAgCu2O-BS NPs applied for 
endophthalmitis after cataract surgery exhibited a 
superior effect and broad prospects. 
Biosafety Study of AuAgCu2O-BS NPs 
Preliminary toxicity of the AuAgCu2O-BS NPs 
was investigated to evaluate their biosafety by H&E 
staining analysis of major organs, including heart, 
liver, spleen, lung, and kidney. As shown in Figure 9 
and Figure S16A, the H&E staining result showed that 
the AuAgCu2O-BS NPs with laser treatment did not 
exhibit significant histological differences. The body 
weight of the rabbits remained stable during 
treatments and was not recognized to be different 
between the four groups (Figure 10A, Figure S16B). 
Moreover, the routine blood examination and the 
liver and kidney function evaluations were in the 
normal range (Figure 10B) and there was no death 
during the treatments. As shown in Figure S17, the 
 
 
Figure 8. Pathologic histology analysis. (A) H&E staining analysis of the cornea and iris indicated the inflammation reaction was inhibited with the AuAgCu2O-BS plus laser 
treatment. Immunohistochemical staining analysis of IL-6 and IL-1β (C) in the cornea and iris indicated the obviously decrease of the cytokine after the AuAgCu2O-BS + Laser 
treatment. 
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NPs did not damage red blood cells (percent 
hemolysis % <5%) indicating the reliable blood 
biocompatibility [57]. The metabolism of AuAgCu2O- 
BS NPs in rabbits was measured by ICP-MS. As 
shown in Figure S18, after 6 days, the concentrations 
of NPs in the eye, liver and feces were higher than 
other tissues and after 12 days the total concentrations 
were lower. After a month almost all nanoparticles 
were metabolized. The results indicated the NPs 
could be removed from eyes and mainly metabolized 
by the liver while the H&E staining of the eye and 
liver did not show obvious change which also indi-
cated the biosafety. Overall, all the results mentioned 
demonstrated that AuAgCu2O-BS NPs applied for 
endophthalmitis are safe and superior in biosafety, 
which has laid the foundation for clinical application. 
Conclusion 
In summary, we developed an AuAgCu2O-BS 
nanosystem to eliminate MDR bacteria, alleviate 
inflammation, and protect the ocular thermal damage 
for postcataract endophthalmitis. We found that the 
released metal ions from the AuAgCu2O-BS NPs 
could kill the clinical MDR bacteria (MRSA) 
effectively both in vitro and in vivo. Meanwhile, the 
delivered bromfenac sodium to the disease sites from 
the nanosystem ensured the anti-inflammatory effect 
and alleviate the relative symptoms to improve the 
prognosis. Importantly, mild temperature 
photothermal treatment is able to control the thermal 
damage to the surrounding ocular structure. 
Moreover, AuAgCu2O-BS NPs did not influence 
intraocular pressure and showed no significant 
toxicity after the treatment. Thus, we have 
demonstrated a promising nanosystem to provide the 
antibacterial and anti-inflammatory effects to treat 
postcataract endophthalmitis, and this strategy may 
contribute to an alternative treatment in the future 
clinical application. 
 
 
Figure 9. Preliminary main visceral organs toxicity study. Toxicological analysis of H&E staining of main visceral organs (heart, liver, spleen, lungs, and kidneys). 
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Figure 10. Changes of body weight (A) with different treatments and blood biochemistry and blood routine examination analyses (B). ALT (alanine 
transferase), AST (aspartate transferase), BUN (blood urea nitrogen), CREA (creatinine), WBC (white blood cells), RDW (red cell distribution width), RBC (red blood cells), PLT 
(blood platelet), MPV (mean platelet volume), HGB (hemoglobin), HDW (hemoglobin distribution width), and HCT (hematocrit). 
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